pmid,title,journal,year,drug,disease
38793571,Challenges in Treating Pediatric Cancer Patients during the COVID-19 Pandemic: Balancing Risks and Care.,Viruses,2024,Paxlovid,Cirrhosis
37730449,Pharmacokinetic drug-drug interactions between Paxlovid(R) (nirmatrelvir/ritonavir) and CFTR modulators for cystic fibrosis.,Therapie,2024,Paxlovid,Cirrhosis
35292968,Physiologically-Based Pharmacokinetic-Led Guidance for Patients With Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor With Nirmatrelvir-Ritonavir for the Treatment of COVID-19.,Clinical pharmacology and therapeutics,2022,Paxlovid,Cirrhosis
